Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Arlington Heights, Oct. 03, 2017 -- The American Society of Plastic Surgeons has two articles that will be published in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), that may be of interest to the general public.
|
|||
Article 1: Plastic Surgeons Get Tips on Managing Opioid Addiction Risk
September 28, 2017 – Opioid medications prescribed for pain management after plastic surgery may contribute to the ongoing opioid epidemic, according to a special topic paper in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Plastic surgeons must recognize their patients' risk of developing opioid use disorders and that the opioids they prescribe may be diverted to non-medical use, according to the article by Daniel Demsey, MD, of University of British Columbia, Vancouver, and colleagues.
"Surgeon opioid prescribing practices contribute to the opioid addiction crisis," Dr. Demsey said. "Improvements in prescribing practices can improve patient safety."
Article 2: Warnings on Anesthesia Before Age 3 – Plastic Surgeons Get Update on Evidence
September 28, 2017 – The evidence behind the U.S. Food and Drug Administration (FDA) recent drug safety warning regarding prolonged anesthesia in infants and young children is discussed in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Pending further research on the possible hazards of anesthesia, elective plastic and reconstructive surgery procedures lasting more than three hours can be delayed until after age 3 if possible, according to the special topic paper by Dr. Christopher Armen Derderian of University of Texas Southwestern Medical Center, Dallas, and colleagues. If surgery can't be delayed, strategies to reduce the child's anesthesia exposure are recommended.
If you'd like to speak with Dr. Demsey or Dr. Derderian about the findings and what they suggest, please contact me at [email protected] or 847-981-5406.Thanks for your time and consideration.
Kim Kubiak
Senior Communications Associate
American Society of Plastic Surgeons
444 East Algonquin Road | Arlington Heights, IL 60005
P: 847-981-5406 | F: 847-981-5474
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/251557da-f752-47eb-9331-345600ce74ee
Kim Kubiak American Society of Plastic Surgeons 847-981-5406 [email protected]
